Shenzhen-based ImmVira’s exosomes-focused subsidiary has struck a partnership with US leading firm Merz Aesthetics. The collaboration is focused on the development of ImmVira’s engineered exosome anti-wrinkle products in the US and Canada.
Partnership Details
The partnership aims to utilize ImmVira’s engineered exosome anti-wrinkle product as the core functional ingredient to upgrade and iterate Merz Aesthetics’ existing cosmetics product line. The goal is to promote these advanced products to the end consumer market, enhancing the aesthetic and anti-aging offerings available to consumers. No financial details were disclosed.
Significance of the Collaboration
This strategic partnership between ImmVira and Merz Aesthetics highlights the potential of exosome technology in the aesthetics and cosmetics industry. By combining ImmVira’s innovative exosome products with Merz Aesthetics’ market presence, the collaboration aims to bring cutting-edge anti-wrinkle solutions to consumers in the US and Canada, potentially setting a new standard in the anti-aging market.-Fineline Info & Tech
